A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01627106
Recruitment Status : Withdrawn
First Posted : June 25, 2012
Last Update Posted : August 26, 2013
Information provided by (Responsible Party):
Cardiome Pharma

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : February 2016
  Estimated Study Completion Date : March 2016